Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Conditioned Medium for Heart Diseases
jRCT1051250143Recruiting
- Sponsor
- Azabu-Juban TT Heart Clinic
- Start
- Oct 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of ACT-20-CM in cardiac disease and heart failure (HF), sponsored by Azabu-Juban TT Heart Clinic. Primary endpoints: Condition of the patient, Frequency of hospitalization and 9 more. Started Oct 2025; status: recruiting.
02
Drugs
ACT-20-CM
03
Conditions
cardiac diseaseheart failure (HF)
Beyond the preview
Go deeper on jRCT1051250143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250143.